In a double-blind study of 34 patients with psoriasis who were placed on either Lipan or a placebo, or both, for 8 to 68 weeks, there were no significant differences in the effects of either one or the other on the course of the disease.
SHAW C. Double-Blind Study of Lipan in the Treatment of Psoriasis. Arch Dermatol. 1963;87(4):462–465. doi:10.1001/archderm.1963.01590160054009
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: